Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 20
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02224820 | Phase II Study, Evaluation of Safety and Efficacy of IdeS in Chronic Kidney Disease | ||
| NCT03943589 | A Study of Imlifidase in Patients With Guillain-Barré Syndrome | ||
| NCT05753930 | Imlifidase Prior to Kidney Transplant in Highly Sensitised Children | ||
| NCT05679401 | A Study With Imlifidase in Anti-GBM Disease | ||
| NCT05714514 | Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys | ||
| NCT04711850 | An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR | ||
| NCT06241950 | A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Imlifidase Infusion in Participants With Duchenne Muscular Dystrophy (DMD) Determined to Have Pre-existing Antibodies to Recombinant Adeno-Associated Virus Serotype (rAAVrh74) | ||
| NCT05937750 | A Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation and a Non-comparative Transplanted Patient Group | ||
| NCT05049850 | A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation | ||
| NCT05369975 | Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts | ||
| NCT03611621 | A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation | ||
| NCT02426684 | Ides in Highly Sensitized (HS) Patients Awaiting Kidney Transplantation | ||
| NCT03157037 | Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease | ||
| NCT02854059 | IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients | ||
| NCT02790437 | A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test | ||
| NCT06518005 | Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome | ||
| NCT01802697 | Safety Study on IdeS in Healthy Volounteers | ||
| NCT04935177 | Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx | ||
| NCT03897205 | An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients | ||
| NCT02475551 | Study to Evaluate the Safety, Tolerability, Efficacy and PK of IdeS in Kidney Transplantation |
